CXM Financial Facts

Grant revenues: 0
Net loss from discontinued operations: 0
See Full Income Statement

Current liabilities: 1.22M
Accrued liabilities: 551.78K
See Full Balance Sheet

Earnings History for Cardium Therapeutics, Inc. (CXM)

  |   Expand Research on CXM
Next EPS Date 8/14/12 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/15/12 Q112 -$0.02N/A N/A N/AN/A N/A / N/A N/A 0% Details
3/30/12 Q411 -$0.02N/A N/A N/AN/A N/A / N/A N/A 0% Details